A study published in the scientific journal Nature Communications found signs that semaglutide, the active ingredient in the medications Ozempic and Wegovy, may have the ability to slow down biological aging. This discovery was considered surprising by the scientists involved in the research, since the anti-aging effect was not the main objective of the study.
The researchers analyzed data from participants who used these medications and identified biological markers that suggest a slowdown in cellular aging processes. This possibility represents a new perspective on the benefits of these drugs beyond their use in the treatment of diabetes and obesity.
The study joins a growing body of research on the effects of these medications, which have been showing benefits in several areas of health. However, scientists warn that more studies are needed to confirm and better understand this connection between semaglutide and biological aging.
